Given that platinum-based chemotherapy is routinely used in clinical management of many types of cancers, and SLC31A1 is ubiquitously expressed in human tissues, validation of these findings in cohorts of lung cancer and other relevant types of cancer with larger sample size would be warranted in different ethnic populations. The gene discussed is SLC31A1; the disease is lung carcinoma.